Kalbe Farma Tbk PT - Asset Resilience Ratio

Latest as of June 2026: 0.46%

Kalbe Farma Tbk PT (KLBF) has an Asset Resilience Ratio of 0.46% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See KLBF working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rp153.40 Billion

≈ $8.99 Million USD Cash + Short-term Investments

Total Assets

Rp33.08 Trillion

≈ $1.94 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Kalbe Farma Tbk PT's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see KLBF total assets.

Liquid Assets Composition Over Time

This chart breaks down Kalbe Farma Tbk PT's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Kalbe Farma Tbk PT strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rp0.00	0%
Short-term Investments	Rp153.40 Billion	0.46%
Total Liquid Assets	Rp153.40 Billion	0.46%

Asset Resilience Insights

Limited Liquidity: Kalbe Farma Tbk PT maintains only 0.46% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Kalbe Farma Tbk PT Industry Peers by Asset Resilience Ratio

Compare Kalbe Farma Tbk PT's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC NYSE:AZN	Drug Manufacturers - General	0.06%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.33%
Sanofi MX:SNYN	Drug Manufacturers - General	0.64%
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	0.00%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	0.06%
Organon & Co NYSE:OGN	Drug Manufacturers - General	4.46%
GuangYuYuan Chinese Herbal Medicine Co Ltd SHG:600771	Drug Manufacturers - General	1.97%

Annual Asset Resilience Ratio for Kalbe Farma Tbk PT (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Kalbe Farma Tbk PT.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.37%	Rp1.96 Trillion ≈ $114.57 Million	Rp30.70 Trillion ≈ $1.80 Billion	-4.61pp
2024-12-31	10.98%	Rp3.23 Trillion ≈ $189.32 Million	Rp29.43 Trillion ≈ $1.72 Billion	+3.30pp
2023-12-31	7.68%	Rp2.08 Trillion ≈ $121.77 Million	Rp27.06 Trillion ≈ $1.59 Billion	-1.35pp
2022-12-31	9.03%	Rp2.46 Trillion ≈ $144.18 Million	Rp27.24 Trillion ≈ $1.60 Billion	-4.93pp
2021-12-31	13.96%	Rp3.58 Trillion ≈ $209.93 Million	Rp25.67 Trillion ≈ $1.50 Billion	+0.35pp
2020-12-31	13.61%	Rp3.07 Trillion ≈ $179.97 Million	Rp22.56 Trillion ≈ $1.32 Billion	+2.48pp
2019-12-31	11.13%	Rp2.26 Trillion ≈ $132.15 Million	Rp20.26 Trillion ≈ $1.19 Billion	-2.91pp
2018-12-31	14.03%	Rp2.55 Trillion ≈ $149.23 Million	Rp18.15 Trillion ≈ $1.06 Billion	+1.26pp
2017-12-31	12.78%	Rp2.12 Trillion ≈ $124.39 Million	Rp16.62 Trillion ≈ $973.65 Million	-3.45pp
2016-12-31	16.22%	Rp2.47 Trillion ≈ $144.75 Million	Rp15.23 Trillion ≈ $892.18 Million	+15.09pp
2015-12-31	1.14%	Rp155.75 Billion ≈ $9.13 Million	Rp13.70 Trillion ≈ $802.56 Million	-0.47pp
2014-12-31	1.60%	Rp199.39 Billion ≈ $11.68 Million	Rp12.43 Trillion ≈ $728.06 Million	-0.05pp
2013-12-31	1.66%	Rp187.74 Billion ≈ $11.00 Million	Rp11.32 Trillion ≈ $663.02 Million	-0.77pp
2012-12-31	2.43%	Rp229.12 Billion ≈ $13.43 Million	Rp9.42 Trillion ≈ $551.85 Million	+1.06pp
2011-12-31	1.38%	Rp113.87 Billion ≈ $6.67 Million	Rp8.27 Trillion ≈ $484.86 Million	+1.30pp
2010-12-31	0.08%	Rp5.32 Billion ≈ $311.49K	Rp7.03 Trillion ≈ $412.08 Million	-0.89pp
2009-12-31	0.97%	Rp62.60 Billion ≈ $3.67 Million	Rp6.48 Trillion ≈ $379.85 Million	-1.22pp
2008-12-31	2.19%	Rp124.75 Billion ≈ $7.31 Million	Rp5.70 Trillion ≈ $334.22 Million	-1.23pp
2007-12-31	3.42%	Rp175.83 Billion ≈ $10.30 Million	Rp5.14 Trillion ≈ $301.08 Million	-2.19pp
2006-12-31	5.62%	Rp259.70 Billion ≈ $15.22 Million	Rp4.62 Trillion ≈ $270.98 Million	-13.44pp
2005-12-31	19.06%	Rp882.99 Billion ≈ $51.74 Million	Rp4.63 Trillion ≈ $271.50 Million	-17.51pp
2004-12-31	36.57%	Rp1.10 Trillion ≈ $64.65 Million	Rp3.02 Trillion ≈ $176.78 Million	+6.24pp
2003-12-31	30.33%	Rp742.67 Billion ≈ $43.52 Million	Rp2.45 Trillion ≈ $143.47 Million	+15.45pp
2002-12-31	14.88%	Rp299.97 Billion ≈ $17.58 Million	Rp2.02 Trillion ≈ $118.10 Million	+13.48pp
2001-12-31	1.41%	Rp26.39 Billion ≈ $1.55 Million	Rp1.88 Trillion ≈ $110.00 Million	-5.44pp
2000-12-31	6.84%	Rp120.31 Billion ≈ $7.05 Million	Rp1.76 Trillion ≈ $103.00 Million	--

pp = percentage points

About Kalbe Farma Tbk PT

JK:KLBF Indonesia Drug Manufacturers - General

Market Cap

$2.04 Billion

Rp34.84 Trillion IDR

Market Cap Rank

#6089 Global

#51 in Indonesia

Share Price

Rp770.00

Change (1 day)

+4.76%

52-Week Range

Rp665.00 - Rp1330.00

All Time High

Rp2271.54